跳至主要内容
临床试验/NL-OMON46378
NL-OMON46378已完成不适用

Symptom scores and pollen monitoring by hay fever patients (SYMPOL) - SYMPO

eids Universitair Medisch Centrum0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Signed an informed consent consistent with ICH-GCP guidelines prior to participating in the trial;
  • * Male or female aged at least 16 years;
  • * Positive anamnesis of hay fever;
  • * Living in the region of Leiden in order to compare the results with the daily pollen counts of the LUMC.
  • * Positive specific IgE test for grass pollen

排除标准

  • * a clinically relevant pet allergy and the very pet at home;
  • * immunotherapy within 3 years prior to visit 1
  • * daily use of inhaled corticosteroids for asthma;
  • * daily use of oral corticosteroids;
  • * pregnant or breast feeding;
  • * chronically blocked nose;
  • * other significant disease (e.g. severe cardiovascular or pulmonary disease, malignancy, autoimmune diseases). Significant is defined as any disease that in the opinion of the investigator would put safety of the subject at risk through participation.

研究者

相似试验